TD Private Client Wealth LLC lessened its holdings in shares of Centene Co. (NYSE:CNC – Free Report) by 91.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 753 shares of the company’s stock after selling 8,476 shares during the quarter. TD Private Client Wealth LLC’s holdings in Centene were worth $46,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of the business. Harris Associates L P boosted its position in shares of Centene by 5.7% in the third quarter. Harris Associates L P now owns 26,314,183 shares of the company’s stock valued at $1,980,932,000 after acquiring an additional 1,420,825 shares during the period. State Street Corp raised its position in shares of Centene by 0.5% in the third quarter. State Street Corp now owns 23,468,159 shares of the company’s stock worth $1,766,683,000 after buying an additional 111,654 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Centene by 3.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,768,534 shares of the company’s stock valued at $434,255,000 after buying an additional 194,566 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Centene by 3.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,803,437 shares of the company’s stock worth $230,412,000 after acquiring an additional 130,895 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC raised its holdings in shares of Centene by 15.4% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 3,203,049 shares of the company’s stock valued at $241,126,000 after acquiring an additional 428,100 shares in the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the stock. Wells Fargo & Company lowered their target price on shares of Centene from $76.00 to $72.00 and set an “overweight” rating on the stock in a research note on Friday, February 14th. Barclays lifted their price objective on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. Oppenheimer lowered their price target on Centene from $95.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday, December 13th. Stephens cut their price objective on Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a report on Friday, December 13th. Finally, Argus cut Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $79.92.
Centene Stock Down 0.8 %
NYSE CNC opened at $58.88 on Wednesday. The business’s 50-day moving average is $60.09 and its 200 day moving average is $62.90. The stock has a market capitalization of $29.21 billion, a PE ratio of 9.44, a PEG ratio of 0.80 and a beta of 0.40. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. Centene Co. has a 1 year low of $55.03 and a 1 year high of $80.59.
Centene (NYSE:CNC – Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.31. The company had revenue of $40.81 billion during the quarter, compared to the consensus estimate of $38.78 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The firm’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.45 earnings per share. Sell-side analysts forecast that Centene Co. will post 6.86 earnings per share for the current year.
Centene Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Recommended Stories
- Five stocks we like better than Centene
- 3 Stocks to Consider Buying in October
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What is a SEC Filing?
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- The How And Why of Investing in Oil Stocks
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.